Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial Pharmacy Times
The process of “deprescribing,” in which a doctor helps a patient taper off a psychiatric medication, is now being considered in the development of federal health policy. Listen to “The Daily.” facebook.com
Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect Psychedelic Alpha
R.F.K. Jr.’s Newest Mission: Getting Us Off Antidepressants The New York Times
FDA recalls popular antidepressant distributed nationwide over cancer concerns the-sun.com
In Defense of the Boxed Warning Cato Institute
Barriers to Care Remain Cato Institute
Long-term antidepressant use may offer limited benefits samaa tv
FDA Recall Affects Nearly 375,000 Antidepressant Bottles Distributed Across the U.S. en.econostrum.info
